Characterization and Analysis of the Proximal Janus Kinase 3 Promoter1

Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase essential for signaling via cytokine receptors that comprise the common γ-chain (γc), i.e., the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Jak3 is preferentially expressed in hemopoietic cells and is up-regulated upon cell differentiation and activation. Despite the importance of Jak3 in lymphoid development and immune function, the mechanisms that govern its expression have not been defined. To gain insight into this issue, we set out to characterize the Jak3 promoter. The 5′-untranslated region of the Jak3 gene is interrupted by a 3515-bp intron. Upstream of this intron and the transcription initiation site, we identified an ∼1-kb segment that exhibited lymphoid-specific promoter activity and was responsive to TCR signals. Truncation of this fragment revealed that core promoter activity resided in a 267-bp fragment that contains putative Sp-1, AP-1, Ets, Stat, and other binding sites. Mutation of the AP-1 sites significantly diminished, whereas mutation of the Ets sites abolished, the inducibility of the promoter construct. Chromatin immunoprecipitation assays showed that histone acetylation correlates with mRNA expression and that Ets-1/2 binds this region. Thus, transcription factors that bind these sites, especially Ets family members, are likely to be important regulators of Jak3 expression.

[1]  J. O’Shea,et al.  Severe combined immune deficiencies due to defects of the common γ chain-JAK3 signaling pathway , 2004, Springer Seminars in Immunopathology.

[2]  J. Johnston,et al.  Regulation of JAK3 expression and activation in human B cells and B cell malignancies. , 1995, Journal of immunology.

[3]  N. Muthusamy,et al.  Defective activation and survival of T cells lacking the Ets-1 transcription factor , 1995, Nature.

[4]  J. Johnston,et al.  Autosomal SCID caused by a point mutation in the N‐terminus of Jak3: mapping of the Jak3–receptor interaction domain , 1999, The EMBO journal.

[5]  H. Nakauchi,et al.  Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. , 1995, Immunity.

[6]  K. Muegge,et al.  Defective T-cell receptor γ gene rearrangement in interleukin-7 receptor knockout mice , 1997 .

[7]  T. Shirasawa,et al.  Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. , 1995, Biochemical and biophysical research communications.

[8]  L. Berg,et al.  Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3. , 1997, DNA and cell biology.

[9]  J. Puck,et al.  Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. , 1997, The Journal of pediatrics.

[10]  L. Notarangelo,et al.  Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase. , 1998, Blood.

[11]  M. Aringer,et al.  Janus kinases and their role in growth and disease. , 1999, Life sciences.

[12]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[13]  Runzhao Li,et al.  Regulation of Ets function by protein–protein interactions , 2000, Oncogene.

[14]  Holger Karas,et al.  TRANSFAC: a database on transcription factors and their DNA binding sites , 1996, Nucleic Acids Res..

[15]  L. Berg,et al.  A Profound Deficiency in Thymic Progenitor Cells in Mice Lacking Jak31 , 2000, The Journal of Immunology.

[16]  A. Sharrocks.  The ETS-domain transcription factor family , 2001, Nature Reviews Molecular Cell Biology.

[17]  A. Villa,et al.  Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene. , 1996, Blood.

[18]  Steven F. Ziegler,et al.  Defective IL7R expression in T-B+NK + severe combined immunodeficiency , 1998, Nature Genetics.

[19]  S. Burakoff,et al.  Involvement of Proteasomes in Regulating Jak-STAT Pathways upon Interleukin-2 Stimulation* , 1997, The Journal of Biological Chemistry.

[20]  You-Wen He,et al.  Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells , 1996, The Journal of experimental medicine.

[21]  C. Griffin,et al.  JAK3: expression and mapping to chromosome 19p12-13.1. , 1997, Experimental hematology.

[22]  A. Sharpe,et al.  Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3 , 1995, Science.

[23]  Kotaro Suzuki,et al.  Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cε transcription of IL-4–stimulated B cells , 2002 .

[24]  J. O’Shea.  Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? , 1997, Immunity.

[25]  Takamune Takahashi,et al.  Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases , 1994, FEBS letters.

[26]  L. Notarangelo,et al.  Complex Effects of Naturally Occurring Mutations in the JAK3 Pseudokinase Domain: Evidence for Interactions between the Kinase and Pseudokinase Domains , 2000, Molecular and Cellular Biology.

[27]  N Muthusamy,et al.  The Ets-1 transcription factor is required for the development of natural killer cells in mice. , 1998, Immunity.

[28]  D. Cohen,et al.  Transcriptional regulation in the immune system: all roads lead to AP‐1 , 1998, Journal of leukocyte biology.

[29]  G. Schuler,et al.  Making effective use of human genomic sequence data. , 1999, Trends in genetics : TIG.

[30]  L. Berg,et al.  T cell development and activation in Jak3‐deficient mice , 1998, Journal of leukocyte biology.

[31]  D. Hilton,et al.  Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1 , 2002, Molecular and Cellular Biology.

[32]  P. Morrissey,et al.  Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. , 1996, Journal of immunology.

[33]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[34]  A. Sher,et al.  A Critical Role for IL-21 in Regulating Immunoglobulin Production , 2002, Science.

[35]  T. Dassopoulos,et al.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.

[36]  T. Shirasawa,et al.  Jak3 expression in glomerular epithelia of IgA nephropathy (IgA‐N) patients , 1996, Clinical and experimental immunology.

[37]  T. Taniguchi,et al.  The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Wasylyk,et al.  The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation , 1990, Nature.

[39]  J. Johnston,et al.  Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Bassuk,et al.  A direct physical association between ETS and AP-1 transcription factors in normal human T cells. , 1995, Immunity.

[41]  J. Johnston,et al.  Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7 , 1995, The Journal of experimental medicine.

[42]  F. Alt,et al.  Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene , 1995, Nature.

[43]  S. Yan,et al.  Complete genomic organization and promoter analysis of the round-spotted pufferfish JAK1, JAK2, JAK3, and TYK2 genes. , 2000, DNA and cell biology.

[44]  J. Burnside,et al.  Molecular cloning of a chicken JAK homolog from activated T cells. , 1998, Gene.

[45]  R. Zinkernagel,et al.  Immune responses in interleukin-2-deficient mice. , 1993, Science.

[46]  J. Ihle,et al.  Signaling by the Cytokine Receptor Superfamily a , 1998, Annals of the New York Academy of Sciences.

[47]  S. Rane,et al.  JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. , 1994, Oncogene.

[48]  I. Horak,et al.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.

[49]  H. Asao,et al.  Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex1 , 2001, The Journal of Immunology.

[50]  J. Verbsky,et al.  Expression of Janus Kinase 3 in Human Endothelial and Other Non-lymphoid and Non-myeloid Cells* , 1996, The Journal of Biological Chemistry.

[51]  H. Griesser,et al.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.

[52]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[53]  R. F. Schumacher,et al.  Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism , 1999, Human Genetics.

[54]  J. Ihle,et al.  A Kinase-deficient Splice Variant of the Human JAK3 Is Expressed in Hematopoietic and Epithelial Cancer Cells (*) , 1995, The Journal of Biological Chemistry.

[55]  C. Gurniak,et al.  Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells. , 1996, Blood.